Agios Pharmaceuticals, Inc.

Q3 2021 13F Holders

Symbol
AGIO
CUSIP
00847X104
Type
Equity
Class
COM
Num filers
169
Total reported value, excl. options
$2.81B
Manager Report Date Value ($000) Shares Option Type